{"id":51548,"date":"2025-12-19T09:36:13","date_gmt":"2025-12-19T08:36:13","guid":{"rendered":"https:\/\/inmuno.es\/index.php\/2025\/12\/19\/the-antigen-presenting-capabilities-of-group-3-innate-lymphoid-cells-insights-into-immunogenic-or-tolerogenic-outcomes-for-t-cells-valuealessia-calabro-sayuri-yamazaki-guido-ferlazzo\/"},"modified":"2025-12-19T09:36:13","modified_gmt":"2025-12-19T08:36:13","slug":"the-antigen-presenting-capabilities-of-group-3-innate-lymphoid-cells-insights-into-immunogenic-or-tolerogenic-outcomes-for-t-cells-valuealessia-calabro-sayuri-yamazaki-guido-ferlazzo","status":"publish","type":"post","link":"https:\/\/inmuno.es\/index.php\/2025\/12\/19\/the-antigen-presenting-capabilities-of-group-3-innate-lymphoid-cells-insights-into-immunogenic-or-tolerogenic-outcomes-for-t-cells-valuealessia-calabro-sayuri-yamazaki-guido-ferlazzo\/","title":{"rendered":"The Antigen Presenting Capabilities of Group 3 Innate Lymphoid Cells: Insights Into Immunogenic or Tolerogenic Outcomes for T Cells. [[{&#8220;value&#8221;:&#8221;Alessia Calabr\u00f2, \nSayuri Yamazaki, \nGuido Ferlazzo, \nStefania Campana&#8221;}]]"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/onlinelibrary.wiley.com\/cms\/asset\/3b73d397-7e62-4a38-9f4b-c7f4d1d0386d\/eji70103-gra-0001-m.png\" alt=\"The Antigen Presenting Capabilities of Group 3 Innate Lymphoid Cells: Insights Into Immunogenic or Tolerogenic Outcomes for T Cells\" \/><\/p>\n<p><b>The Janus face of group 3 innate lymphoid cells (ILC3s)<\/b>. ILC3s are highly plastic and can adapt their immunoregulatory roles according to the local context, balancing tolerance and activation. Influenced by tissue-specific environmental cues, they can express MHC class II molecules either alone or jointly with costimulatory molecules, therefore presenting acquired antigens for controlling or triggering CD4<sup>+<\/sup> T cell activities.<\/p>\n<p><\/p>\n<h2>ABSTRACT<\/h2>\n<p>Group 3 innate lymphoid cells (ILC3s) are tissue-resident lymphocytes distributed across both lymphoid and non-lymphoid tissues, capable of mounting rapid immune responses. They are defined by expression of the transcription factor ROR\u03b3t and comprise distinct subsets, including lymphoid tissue inducer-like cells expressing major histocompatibility complex class II (MHCII). These MHCII\u207a ILC3s can directly present antigens to CD4\u207a T cells, a function regulated by the transcriptional activator CIITA through a pathway similar to thymic epithelial cells. ILC3s contribute to immune homeostasis by limiting effector T cell responses and promoting regulatory T cell differentiation. However, under the influence of distinct cytokine milieus, such as IL-1\u03b2 and IFN-\u03b3, ILC3s undergo a <i>maturation<\/i> process, upregulating costimulatory molecules and enhancing their antigen-presenting capacity to activate CD4\u207a T cells. This dual functionality is highly plastic and influenced by tissue-specific environmental cues, enabling ILC3s to adapt their immunoregulatory roles according to local context. Overall, ILC3s now emerge as critical modulators of T cell activities, balancing tolerance and activation, with significant implications for host defense, autoimmunity, inflammation, and cancer.<\/p>","protected":false},"excerpt":{"rendered":"<p>The Janus face of group 3 innate lymphoid cells (ILC3s). ILC3s are highly plastic and can adapt their immunoregulatory roles according to the local context, balancing tolerance and activation. Influenced by tissue-specific environmental cues, they can express MHC class II molecules either alone or jointly with costimulatory molecules, therefore presenting acquired antigens for controlling or &#8230; <a title=\"The Antigen Presenting Capabilities of Group 3 Innate Lymphoid Cells: Insights Into Immunogenic or Tolerogenic Outcomes for T Cells. [[{&#8220;value&#8221;:&#8221;Alessia Calabr\u00f2, \nSayuri Yamazaki, \nGuido Ferlazzo, \nStefania Campana&#8221;}]]\" class=\"read-more\" href=\"https:\/\/inmuno.es\/index.php\/2025\/12\/19\/the-antigen-presenting-capabilities-of-group-3-innate-lymphoid-cells-insights-into-immunogenic-or-tolerogenic-outcomes-for-t-cells-valuealessia-calabro-sayuri-yamazaki-guido-ferlazzo\/\" aria-label=\"Read more about The Antigen Presenting Capabilities of Group 3 Innate Lymphoid Cells: Insights Into Immunogenic or Tolerogenic Outcomes for T Cells. [[{&#8220;value&#8221;:&#8221;Alessia Calabr\u00f2, \nSayuri Yamazaki, \nGuido Ferlazzo, \nStefania Campana&#8221;}]]\">Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[112,42],"tags":[],"class_list":["post-51548","post","type-post","status-publish","format-standard","hentry","category-european-journal-of-immunology","category-publicaciones"],"_links":{"self":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/posts\/51548","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/comments?post=51548"}],"version-history":[{"count":0,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/posts\/51548\/revisions"}],"wp:attachment":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/media?parent=51548"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/categories?post=51548"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/tags?post=51548"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}